Search

everythinglearnresearchcommunity

for

Search:↓

Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

The authors maintain that shorter androgen receptor alleles may lead to milder COVID-19 by positively affecting the immune response, not due to changes in testosterone levels or activity.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

New understanding and treatments for hair loss are improving, but more research is needed.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

Dutasteride and finasteride affect different cell types differently.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Certain Dibenzo derivatives may help treat prostate cancer.

Use telemedicine and strict hygiene for safe hair and scalp treatments during COVID-19.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Women with high androgen levels may have more severe COVID-19 symptoms.

Mutations in certain receptors can cause diseases and offer new treatment options.

Anabolic steroid users may face higher risk of severe COVID-19.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Possible link between androgens and COVID-19 severity; more research needed.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.